Literature DB >> 27386207

The lipogenic regulator Sterol Regulatory Element Binding Factor-1c is required to maintain peripheral nerve structure and function.

Nico Mitro1, Gaia Cermenati1, Matteo Audano1, Silvia Giatti1, Maurizio D'Antonio2, Emma De Fabiani1, Maurizio Crestani1, Enrique Saez3, Inigo Azcoitia4, Guido Cavaletti5, Luis-Miguel Garcia-Segura6, Roberto C Melcangi1, Donatella Caruso1.   

Abstract

Entities:  

Keywords:  Peripheral neuropathy; Schwann cells; metabolism

Year:  2015        PMID: 27386207      PMCID: PMC4798017          DOI: 10.1186/2193-1801-4-S1-L45

Source DB:  PubMed          Journal:  Springerplus        ISSN: 2193-1801


× No keyword cloud information.
Myelin is a membrane characterized by high lipid content to facilitate impulse propagation. Changes in myelin fatty acid (FA) composition have been associated with peripheral neuropathy [1], but the specific role of peripheral nerve FA synthesis in myelin formation and function is poorly understood. We explored the extent to which lack of the key regulator of FA synthesis as Sterol Regulatory Element Binding Factor-1c (Srebf-1c) could result in the development of peripheral neuropathy. We found that Srebf-1c null mice display a neuropathic phenotype consisting in hypermyelinated small caliber fibers, the result of changes in myelin periodicity. Unexpectedly, transcriptomics and metabolomics revealed activation of peroxisome proliferator activated receptor α (Pparα) signaling in Srebf-1c null peripheral nerve as a result of increased levels of two distinct phosphatidylcholine-based Pparα ligands, PC-C16:0/C18:1 and PC-C18:0/C18:1 [2, 3]. Pparα is a nuclear receptor that directs uptake, utilization and catabolism of FAs [4]. As a consequence of abnormal local Pparα activation, Srebf-1c null peripheral nerve exhibit increased fatty acid utilization, a detrimental condition leading to peripheral neuropathy. Treatment with a Pparα antagonist rescues the neuropathy of Srebf-1c null mice. These findings reveal the importance of FA synthesis to sustain peripheral nerve structure and function.
  4 in total

Review 1.  Control of metabolism by nutrient-regulated nuclear receptors acting in the brain.

Authors:  Kadiombo Bantubungi; Janne Prawitt; Bart Staels
Journal:  J Steroid Biochem Mol Biol       Date:  2011-10-17       Impact factor: 4.292

2.  Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation.

Authors:  Gaia Cermenati; Federico Abbiati; Solei Cermenati; Elisabetta Brioschi; Alessandro Volonterio; Guido Cavaletti; Enrique Saez; Emma De Fabiani; Maurizio Crestani; Luis M Garcia-Segura; Roberto C Melcangi; Donatella Caruso; Nico Mitro
Journal:  J Lipid Res       Date:  2011-12-07       Impact factor: 5.922

3.  Identification of a physiologically relevant endogenous ligand for PPARalpha in liver.

Authors:  Manu V Chakravarthy; Irfan J Lodhi; Li Yin; Raghu R V Malapaka; H Eric Xu; John Turk; Clay F Semenkovich
Journal:  Cell       Date:  2009-07-30       Impact factor: 41.582

4.  A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use.

Authors:  Sihao Liu; Jonathan D Brown; Kristopher J Stanya; Edwin Homan; Mathias Leidl; Karen Inouye; Prerna Bhargava; Matthew R Gangl; Lingling Dai; Ben Hatano; Gökhan S Hotamisligil; Alan Saghatelian; Jorge Plutzky; Chih-Hao Lee
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.